Form 4: Cassava Sciences Director, Patrick J. Scannon, Receives Stock Options

Director Patrick J. Scannon received 10,000 stock options in Cassava Sciences Inc. on May 9, 2024, as part of the Non-employee Director Compensation Program.

Summary

• On May 9, 2024, Patrick J. Scannon, a director of Cassava Sciences Inc., was granted 10,000 stock options.
• The options have an exercise price of $21.11.
• These options were granted pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023.
• The stock options vest over a one-year period, at a rate of 1/12 per month, and expire on May 9, 2034.
• Following the transaction, Scannon directly owns 10,000 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a standard practice and indicates confidence in the company's future, but it's not a major event.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and contribution to the company over the next year.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the options.

Industry Context

Granting stock options to directors is a common practice to incentivize and align their interests with the long-term success of the company, particularly in the biotech industry where long-term research and development are crucial.

Comparison to Industry Standards

• Stock option grants to non-employee directors are a standard component of compensation packages in publicly traded companies, especially in the biotech sector.
• The vesting schedule of one year is fairly typical, aligning with industry norms for incentivizing continued service.
• Comparable companies like Biogen or Amgen also utilize stock options as part of their director compensation packages.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of shareholders, potentially leading to decisions that benefit the company's long-term value.
• Employees may view the grant as a positive sign of the company's commitment to its leadership.

Key Dates